Bhasin, Namita, Manoj Kumar Sharma, Dr. Narender Yadav, and Dr. Mukesh Kumar Kumawat. “Diabetes Ketoacidosis Is a Cause of Concern in Sodium-Glucose Co-Transporter-2 Inhibitors Medication: Pharmaceutical Science-Pharmaceutics”. International Journal of Life Science and Pharma Research 13, no. SP 1 (December 31, 2022): P55-P67. Accessed February 1, 2026. https://ijlpr.com/index.php/journal/article/view/1549.